Melittin inhibits TGF-β-induced pro-fibrotic gene expression through the suppression of the TGFβRII-Smad, ERK1/2 and JNK-mediated signaling pathway

Am J Chin Med. 2014;42(5):1139-52. doi: 10.1142/S0192415X14500712. Epub 2014 Sep 1.

Abstract

Renal fibrosis is characterized by the excessive accumulation of extracellular matrix (ECM) proteins such as type I collagen, fibronectin, and by the increased expression of PAI-1. This study evaluated the anti-fibrotic effect of bee venom and its major compounds (melittin and apamin) on TGF-β-induced pro-fibrotic gene expression. Bee venom and melittin significantly suppressed type I collagen, fibronectin, and PAI-1 protein expression in the TGF-β-treated kidney fibroblast. However, apamin only inhibited the expression of fibronectin and type I collagen. These results indicated that the inhibitory effects of bee venom on TGF-β-induced pro-fibrotic gene expression are caused by melittin. Moreover, we attempted to elucidate mechanisms underlying the anti-fibrotic effect of melittin. Melittin dramatically inhibited the phosphorylation of TGFβRII and Smad2/3. Also, melittin inhibited the phosphorylation of ERK1/2 and JNK, but not the phosphorylation of PI3K, Akt, and p38. These results suggested that melittin inhibits TGF-β-induced pro-fibrotic genes expression through the suppression of TGFβR-Smad2/3, ERK1/2, and JNK phosphorylation, and melittin can be used as a clinical drug for the treatment of fibrosis associated with renal diseases.

Keywords: Bee Venom; Melittin; Pro-Fibrotic Factor; Renal Fibrosis; Transforming Growth Factor-β.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bee Venoms / pharmacology*
  • Cells, Cultured
  • Collagen Type I / genetics*
  • Collagen Type I / metabolism*
  • Depression, Chemical
  • Fibroblasts / pathology*
  • Fibronectins / genetics*
  • Fibronectins / metabolism*
  • Fibrosis
  • Gene Expression / drug effects*
  • Gene Expression / genetics*
  • Kidney / cytology
  • Kidney / pathology*
  • Kidney Diseases / drug therapy
  • Kidney Diseases / pathology
  • MAP Kinase Signaling System / drug effects*
  • MAP Kinase Signaling System / genetics*
  • Melitten / pharmacology*
  • Melitten / therapeutic use
  • Phosphorylation / drug effects
  • Plasminogen Activator Inhibitor 1 / genetics*
  • Plasminogen Activator Inhibitor 1 / metabolism*
  • Protein Serine-Threonine Kinases / metabolism*
  • Rats
  • Receptor, Transforming Growth Factor-beta Type II
  • Receptors, Transforming Growth Factor beta / metabolism*
  • Signal Transduction / drug effects*
  • Signal Transduction / genetics*
  • Smad Proteins / metabolism*
  • Transforming Growth Factor beta / antagonists & inhibitors*

Substances

  • Bee Venoms
  • Collagen Type I
  • Fibronectins
  • Plasminogen Activator Inhibitor 1
  • Receptors, Transforming Growth Factor beta
  • Smad Proteins
  • Transforming Growth Factor beta
  • Melitten
  • Protein Serine-Threonine Kinases
  • Receptor, Transforming Growth Factor-beta Type II